Cell and enzyme compositions for modulating bile acids,...

Details Cell and enzyme compositions for modulating bile acids,... Cell and enzyme compositions for modulating bile acids,...

2011-05-10

2011-05-10

Afremova, Vera (Department: 1657)

Drug, bio-affecting and body treating compositions

Whole live micro-organism, cell, or virus containing

Bacteria or actinomycetales

C424S093100, C424S093450

Reexamination Certificate

active

07939061

ABSTRACT:
The invention relates to immobilized or encapsulated enzyme and/or cells to lower bile acids and cholesterol. The invention also relates to methods of quantitatively measuring bile acids. The invention provides a composition for decreasing the amount of a target compound in the gastrointestinal tract of an animal, comprising: a) a biologically active agent which decreases the amount of the target compound; b) a retainer for retaining the biologically active agent by contacting the agent to limit movement of the agent; and c) a carrier.

REFERENCES:
patent: 4362711 (1982-12-01), Cerami
patent: 6217859 (2001-04-01), Chang et al.
patent: 6365148 (2002-04-01), Kim et al.
patent: 2243352 (1997-07-01), None
patent: 1 433 525 (2004-06-01), None
patent: 2001069990 (2001-03-01), None
patent: WO 93/05161 (1993-03-01), None
patent: WO 97/16529 (1997-05-01), None
patent: WO 98/27199 (1998-06-01), None
patent: WO 99/27953 (1999-06-01), None
patent: WO 01/88095 (2001-12-01), None
Liu et al. “Alginate-pectin-polylysine particulate as potential controlled release formulation”. J. Pharm. Pharmacol. 1999, 51:141-149.
Corzo et al. Journal of Dairy Science. 1999, vol. 82, No. 3, pp. 466-471.
Christiaens et al. Applied and Environmental Microbiology. 1992, vol. 58, No. 12, pp. 3792-3798.
Shah et al. Australian Jouranl of Dairy Technology, 2000, vol. 55, No. 3, pp. 139-144.
Thornton et al. (Gastroenterology. 1995, vol. 108, No. 4, AGA Abstracts, A928.
De Smet, I. et al., “In vitro study of bile salt hydrolase (BSH) activity of BSH isogenicLactobacillus plantrarum80 strains and estimation of cholesterol lowering through enhanced BSH activity”, Microbial Ecology in Health and Disease, 1994, pp. 315-329, vol. 7, No. 6.
Chang, T. et al., Artificial cells for bioencapsulation of cells and genetically engineeredE. coli: For cell therapy, gene therapy, and removal of urea and ammonia, Methods in Molecular Biology; Recombinant Protein Protocols: Detection, 1997, pp. 343-358, 1997 Humana Press Inc., New Jersey, USA.
Chang, T. et al., “Therapeutic uses of microencapsulated genetically engineered cells”, Molecular Medicine Today, Elsevier, Cambridge, GB, May 1998, pp. 221-227.
Taranto, M. P. et al., “Effect ofLactobacillus reuterion the prevention of hypercholesterolemia in mice”, Journal of Dairy Science, Mar. 2000, pp. 401-403, vol. 83, No. 3, USA.
De Boever, P. et al., “Protective effect of the bile salt hydrolase-activeLactobacillus reuteriagainst bile salt cytotoxicity”, Applied Microbiology and Biotechnology, Jun. 2000, pp. 709-714, vol. 53, No. 6.
Casas, I. et al., “Validation of the probiotic concept:Lactobacillus reutericonfers broad-spectrum protection against disease in humans and animals”, Microbial Ecology in Health and Disease, Nov. 2000, pp. 247-285, vol. 12, No. 4.
Jones, M. et al., “Deconjugation of Bile Acids with Immobilized Genetically EngineeredLactobacillus plantarum80 (pCBH1)”, 6thInternational Congress of the Cell Transplant Society, Mar. 2003, Atlanta, USA (Poster).
Jones, M. et al., “Deconjugation of Bile Acids with Immobilized Genetically EngineeredLactobacillus plantarum80 (pCBH1)”, 6thInternational Congress of the Cell Transplant Society, Mar. 2003, Atlanta, USA (Abstract).
Jones, M., “Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and its Implication in Lowering Cholesterol”, Department of Biomedical Engineering, McGill University, Oct. 2003, Montreal, Canada.
Jones, M. et al., “Microencapsulated Genetically EngineeredLactobacillus plantarum80 (pCBH1) for Bile Acid Deconjugation and its Implication in Lowering Cholesterol”, Journal of Biomedicine and Biotechnology, 2004:1 (2004) 61-69.
Jones, M. et al., “Deconjugation of Bile Acids with Immobilized Genetically EngineeredLactobacillus plantarum80 (pCBH1)”, Applied Bionics and Biomechanics, 2005, vol. 2, No. 1, pp. 31-38.
Wang, X. L. and Shao, J.Y., “New Preparation for Oral Administration of Digestive Enzyme. Lactase Complex Microcapsules”, Biomaterials, Artificial Cells, and Immobilization Biotechnology, 1993, pp. 637-646, vol. 21, No. 5.
Buisson, P., et al., “Encapsulation of lipases in aerogels”, Journal of Non-Crystalline Solids, 2001, pp. 295-302, vol. 285, No. 1-3, North-Holland Publishing Company, Amsterdam, NL.
Kato, K., et al., “Preparation and Catalytic Performance of Lipases Encapsulated in Sol-Gel Materials”, Bioscience Biotechnology and Biochemistry, 2002, pp. 221-223, vol. 66, No. 1.
De Smet, I., et al., “Cholesterol lowering in pigs through enhanced bacterial bile salt hydrolase activity”, British Journal of Nutrition, 1998, pp. 185-194, vol. 79.
De Boever, P. and Verstraete, W., Bile salt deconjugation byLactobacillus plantarum80 and its implication for bacterial toxicity, Journal of Applied Microbiology, 1999, pp. 345-352, vol. 87.
Begley, M., et al., “Bile Salt Hydrolase Activity in Probiotics”, Applied and Environmental Microbiology, 2006, pp. 1729-1738, vol. 72, No. 3.
Fávaro-Trindade, C.S., et al. “Microencapsulation ofL. acidophilus(Ia-05) andB. lactis(Bb-12) and evaluation of their survival at the pH values of the stomach and in bile”, Journal of Microencapsulation, 2002, pp. 485-494, vol. 19, No. 4.
Ye, Z., et al., “Cultivation ofLactobacillusin microcapsule”, Wei Sheng Wu Xue Bao, Oct. 2000, pp. 507-512, vol. 40, No. 5 (Abstract Only).
Martoni, C., et al., “Investigation of Microencapsulated BSH ActiveLactobacillusin the Simulated Human GI Tract”, Journal of Biomedicine and Biotechnology, 2007, pp. 1-9, vol. 2007.
Garrigues, C. et al., “Characterisation ofBifidobacterium animalissubsp. lactis BB-12 and other probiotic bacteria using genomics, transcriptomics and proteomics”, The Australian Journal of Dairy Technology, 2005, pp. 84-92, vol. 60, No. 2.
Ahn, Y.T. and Kim, H.U., “Bile salts deconjugtion of lactic acid bacteria found in the feces of normal Korean adults and in fermented milk products”, Kor. J. Anim. Sci., 1999, pp. 183-192, vol. 41, No. 2.
Ahn, Y.T., et al., “Study on Bile Salts Deconjugation of Lactic Acid Bacteria Found in the Feces of Normal Korean Adults in Fermented Milk Products”, Journal of Korean Livestock, 1999, pp. 183-192, vol. 41, No. 2. (translation).

Affiliated with

Also associated with

Rating

Cell and enzyme compositions for modulating bile acids,... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Cell and enzyme compositions for modulating bile acids,..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cell and enzyme compositions for modulating bile acids,... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-2701791